In the BioHarmony Drug Report Database

"Preview" Icon

Fluocinolone acetonide

Capex, Derma-smoothe/fs, Dermotic, Iluvien, Retisert, Synalar, Synalar-hp, Yutiq (fluocinolone acetonide) is a small molecule pharmaceutical. Fluocinolone acetonide was first approved as Capex on 1982-01-01. It is used to treat atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. Neo-synalar’s patent is valid until 2027-08-12 (FDA).

 

Trade Name

 

Capex, Derma-smoothe/fs, Dermotic, Iluvien, Retisert, Synalar, Synalar-hp, Yutiq
 

Common Name

 

fluocinolone acetonide
 

ChEMBL ID

 

CHEMBL989
 

Indication

 

atopic dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, pruritus, psoriasis, scalp dermatoses
 

Drug Class

 

Steroids (not prednisolone derivatives); topical steroids (acetal derivatives)

Image (chem structure or protein)

Fluocinolone acetonide structure rendering